Sunbird Bio

Cambridge, MA · Founded 2020 · Privately Held (backing)

Developer of a diagnostics platform designed to provide fast and accurate results in molecular diagnostics. Sunbird Bio is based in Cambridge, MA and was founded in 2020. Its last reported valuation was $16 million in Nov 2022. It has raised $27.3 million across 1 recorded round; the latest was a $23.2 million early-stage round in Apr 2023.

Last reported valuation
$16.0M
Oct 2026
Priced at
—
Total raised
$27.3M
Last round
Early Stage VC
Apr 2023

Who backs Sunbird Bio?

11 investors
InvestorType
Alumni VenturesVenture capital
EDBIVenture capital
ARCH Venture PartnersVenture capital
S32Venture capital
Polaris PartnersVenture capital
DNS CapitalFamily office
New Leaf VentureVenture capital
ClavystBioOther
Alzheimers Drug Discovery Foundation—
Eli Lilly—
+ 1 more investors · a free Private Market View account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Sunbird Bio investors

11 investors are on record for Sunbird Bio, including Alumni Ventures, EDBI, ARCH Venture Partners and S32. By type, the record holds 6 venture capital firms and 1 family office. The early-stage round in Apr 2023 drew 10 investors.

Private Market View
More of Sunbird Bio with a free Private Market View account
  • ·The complete investor list: 11 names
  • ·Watch Sunbird Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like Sunbird Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View